Sana Biotechnology, Inc. (SANA) Misses Q1 EPS by 1c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
• Visteon (VC) 354 contracts of June 120 calls as share price up 6%